Targeting an Autocrine Regulatory Loop in Cancer Stem-like Cells Impairs the Progression and Chemotherapy Resistance

Kai-Jian Wang1, Chao Wang1, Li-He Dai1

  • 1Department of Urology, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai, China.

Abstract

Insights

Blocking a specific signaling loop in cancer stem cells can overcome chemotherapy resistance in bladder cancer. This finding offers a potential new treatment strategy for advanced bladder cancer patients.

Area of Science:

  • Oncology
  • Cancer Stem Cell Biology
  • Chemotherapy Resistance Mechanisms

Background:

  • Cancer stem-like cells (CSCs) are implicated in bladder cancer progression and resistance to chemotherapy.
  • The precise molecular mechanisms driving CSC-mediated resistance remain incompletely understood.
  • This study investigates a potential autocrine signaling loop within CSCs contributing to therapeutic failure.

Purpose of the Study:

  • To determine if inhibiting an autocrine signaling loop in bladder cancer stem cells can enhance the efficacy of cisplatin chemotherapy.
  • To elucidate the role of OV6 expression and associated signaling pathways in bladder cancer stem cell properties and chemoresistance.

Main Methods:

  • Immunohistochemistry (IHC) was used to assess OV6 expression in human bladder cancer tissues.
  • Magnetic-activated cell sorting (MACS) isolated OV6+ and OV6- bladder cancer cells for functional assays.
  • Molecular analyses included RNA-Seq, cytokine arrays, co-IP, ChIP, and an orthotopic mouse model to test YAP and PDGFR inhibitors.

Main Results:

  • High OV6 expression correlated with advanced bladder cancer, poor prognosis, and enhanced CSC characteristics (self-renewal, tumor initiation, chemoresistance).
  • The YAP/TEAD1 pathway was identified as crucial for maintaining OV6+ CSC stemness and triggering PDGFB transcription.
  • Inhibition of the YAP/TEAD1/PDGF-BB/PDGFR signaling loop using verteporfin or CP-673451 significantly reduced cisplatin resistance in OV6+ bladder cancer CSCs in vivo.

Conclusions:

  • OV6 serves as a potential biomarker for bladder cancer progression and patient prognosis.
  • Targeting the autocrine YAP/TEAD1/PDGF-BB/PDGFR signaling loop represents a promising therapeutic strategy to overcome cisplatin resistance.
  • This approach may offer a novel treatment option for patients with advanced bladder cancer exhibiting chemoresistance.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.0K
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells01:18

Distinctive Features of Adult Stem Cells vs Cancer Stem Cells

A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
4.5K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.3K